1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Absorbable Antibacterial Envelope Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Absorbable Antibacterial Envelope Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/globally
5.3. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry
6. Global Absorbable Antibacterial Envelope Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Application, 2017–2031
6.3.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
6.3.2. Implantable Cardioverter Defibrillators (ICD)
6.3.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)
6.4. Market Attractiveness Analysis, by Application
7. Global Absorbable Antibacterial Envelope Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Absorbable Antibacterial Envelope Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Absorbable Antibacterial Envelope Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2017–2031
9.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
9.2.2. Implantable Cardioverter Defibrillators (ICD)
9.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Absorbable Antibacterial Envelope Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017–2031
10.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
10.2.2. Implantable Cardioverter Defibrillators (ICD)
10.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Absorbable Antibacterial Envelope Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017–2031
11.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
11.2.2. Implantable Cardioverter Defibrillators (ICD)
11.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Absorbable Antibacterial Envelope Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017–2031
12.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
12.2.2. Implantable Cardioverter Defibrillators (ICD)
12.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Absorbable Antibacterial Envelope Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017–2031
13.2.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
13.2.2. Implantable Cardioverter Defibrillators (ICD)
13.2.3. Cardiac Resynchronization Therapy Pacemakers (CRT-P)
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Medtronic plc
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Aziyo Biologics, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
世界の吸収可能型抗菌エンベロープ市場2022-2031：用途別（植込み型除細動器（ICD）、心臓再同期療法用除細動器（CRT-D）、心臓再同期療法用ペースメーカー） |
| 【英語タイトル】Absorbable Antibacterial Envelope Market (Application: Implantable Cardioverter Defibrillators [ICDs], Cardiac Resynchronization Therapy Defibrillators [CRT-D), and Cardiac Resynchronization Therapy Pacemakers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 | |
 | ・商品コード：TMR23FB020 ・発行会社（調査会社）：Transparency Market Research ・発行日：2022年12月6日 ・ページ数：110 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後24時間以内） ・調査対象地域：グローバル ・産業分野：医療 |
| Single User（1名様閲覧） | USD5,795 ⇒換算￥869,250 | 見積依頼/購入/質問フォーム |
| Multi User（5名様閲覧） | USD8,795 ⇒換算￥1,319,250 | 見積依頼/購入/質問フォーム |
| Corporate License（法人閲覧） | USD11,795 ⇒換算￥1,769,250 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| Transparency Market Research社の市場調査では、2022年に32.5百万ドルであった世界の吸収可能型抗菌エンベロープ市場規模が2031年には56.9百万ドルまで達し、予測期間中に年平均5.8％成長すると予測しています。当書では、吸収可能型抗菌エンベロープの世界市場について広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、用途別（心臓再同期療法用除細動器（CRT-D）、植込み型除細動器（ICD）、心臓再同期療法用ペースメーカー）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競合状況などの項目を掲載しています。また、当書には、Medtronic plc、Aziyo Biologics, Inc.などの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要洞察 ・世界の吸収可能型抗菌エンベロープ市場規模：用途別 - 心臓再同期療法用除細動器（CRT-D）における市場規模 - 植込み型除細動器（ICD）における市場規模 - 心臓再同期療法用ペースメーカーにおける市場規模 ・世界の吸収可能型抗菌エンベロープ市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の吸収可能型抗菌エンベロープ市場規模：地域別 - 北米の吸収可能型抗菌エンベロープ市場規模 - ヨーロッパの吸収可能型抗菌エンベロープ市場規模 - アジア太平洋の吸収可能型抗菌エンベロープ市場規模 - 中南米の吸収可能型抗菌エンベロープ市場規模 - 中東・アフリカの吸収可能型抗菌エンベロープ市場規模 ・競合状況 |
Absorbable Antibacterial Envelope Market – Scope of Report
TMR’s report on the global absorbable antibacterial envelope market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global absorbable antibacterial envelope market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global absorbable antibacterial envelope market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the absorbable antibacterial envelope market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global absorbable antibacterial envelope market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global absorbable antibacterial envelope market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global absorbable antibacterial envelope market.
The report delves into the competitive landscape of the global absorbable antibacterial envelope market. Key players operating in the global absorbable antibacterial envelope market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global absorbable antibacterial envelope market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market absorbable antibacterial envelope.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
❖ レポートの目次 ❖
| ★調査レポート[世界の吸収可能型抗菌エンベロープ市場2022-2031：用途別（植込み型除細動器（ICD）、心臓再同期療法用除細動器（CRT-D）、心臓再同期療法用ペースメーカー）] (コード：TMR23FB020)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の吸収可能型抗菌エンベロープ市場2022-2031：用途別（植込み型除細動器（ICD）、心臓再同期療法用除細動器（CRT-D）、心臓再同期療法用ペースメーカー）]についてメールでお問い合わせ |
